Ubs Group Ag Liva Nova PLC Transaction History
Ubs Group Ag
- $555 Billion
- Q2 2025
A detailed history of Ubs Group Ag transactions in Liva Nova PLC stock. As of the latest transaction made, Ubs Group Ag holds 315,873 shares of LIVN stock, worth $16 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
315,873
Previous 745,400
57.62%
Holding current value
$16 Million
Previous $29.3 Million
51.43%
% of portfolio
0.0%
Previous 0.01%
Shares
34 transactions
Others Institutions Holding LIVN
# of Institutions
271Shares Held
55.7MCall Options Held
75.5KPut Options Held
73.1K-
Black Rock Inc. New York, NY6.9MShares$350 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA4.64MShares$235 Million0.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.45MShares$124 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.43MShares$123 Million0.06% of portfolio
-
State Street Corp Boston, MA2.08MShares$105 Million0.0% of portfolio
About LivaNova PLC
- Ticker LIVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 53,545,700
- Market Cap $2.71B
- Description
- LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...